• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诺如病毒抗原拓扑结构的 B 细胞和 T 细胞表位作图定义:对通用疫苗和治疗的影响。

The Antigenic Topology of Norovirus as Defined by B and T Cell Epitope Mapping: Implications for Universal Vaccines and Therapeutics.

机构信息

Caliciviruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, DHHS, Bethesda, MD 20892, USA.

出版信息

Viruses. 2019 May 10;11(5):432. doi: 10.3390/v11050432.

DOI:10.3390/v11050432
PMID:31083353
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6563215/
Abstract

Human norovirus (HuNoV) is the leading cause of acute nonbacterial gastroenteritis. Vaccine design has been confounded by the antigenic diversity of these viruses and a limited understanding of protective immunity. We reviewed 77 articles published since 1988 describing the isolation, function, and mapping of 307 unique monoclonal antibodies directed against B cell epitopes of human and murine noroviruses representing diverse Genogroups (G). Of these antibodies, 91, 153, 21, and 42 were reported as GI-specific, GII-specific, MNV GV-specific, and G cross-reactive, respectively. Our goal was to reconstruct the antigenic topology of noroviruses in relationship to mapped epitopes with potential for therapeutic use or inclusion in universal vaccines. Furthermore, we reviewed seven published studies of norovirus T cell epitopes that identified 18 unique peptide sequences with CD4- or CD8-stimulating activity. Both the protruding (P) and shell (S) domains of the major capsid protein VP1 contained B and T cell epitopes, with the majority of neutralizing and HBGA-blocking B cell epitopes mapping in or proximal to the surface-exposed P2 region of the P domain. The majority of broadly reactive B and T cell epitopes mapped to the S and P1 arm of the P domain. Taken together, this atlas of mapped B and T cell epitopes offers insight into the promises and challenges of designing universal vaccines and immunotherapy for the noroviruses.

摘要

人类诺如病毒(HuNoV)是急性非细菌性胃肠炎的主要原因。这些病毒的抗原多样性以及对保护性免疫的有限了解,使得疫苗设计变得复杂。我们回顾了自 1988 年以来发表的 77 篇描述针对人类和鼠诺如病毒 B 细胞表位的分离、功能和定位的文章,这些病毒代表了不同的基因群(G)。在这些抗体中,91、153、21 和 42 分别被报道为 GI 特异性、GII 特异性、MNV GV 特异性和 G 交叉反应性。我们的目标是重建诺如病毒的抗原拓扑结构,与潜在用于治疗或包含在通用疫苗中的映射表位相关。此外,我们还回顾了七项已发表的诺如病毒 T 细胞表位研究,这些研究确定了 18 个具有 CD4 或 CD8 刺激活性的独特肽序列。主要衣壳蛋白 VP1 的突出(P)和壳(S)结构域均包含 B 和 T 细胞表位,大多数中和和 HBGA 阻断 B 细胞表位位于 P 域表面暴露的 P2 区域内或附近。大多数广泛反应的 B 和 T 细胞表位定位于 P 域的 S 和 P1 臂。总的来说,这个映射的 B 和 T 细胞表位图谱为设计通用疫苗和诺如病毒免疫疗法提供了深入了解其前景和挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a72a/6563215/28b5ea9be220/viruses-11-00432-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a72a/6563215/5d1b5169890f/viruses-11-00432-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a72a/6563215/97b094d108a6/viruses-11-00432-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a72a/6563215/3add54cdf002/viruses-11-00432-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a72a/6563215/a2018bbf8b00/viruses-11-00432-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a72a/6563215/3003ec7916b6/viruses-11-00432-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a72a/6563215/28b5ea9be220/viruses-11-00432-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a72a/6563215/5d1b5169890f/viruses-11-00432-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a72a/6563215/97b094d108a6/viruses-11-00432-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a72a/6563215/3add54cdf002/viruses-11-00432-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a72a/6563215/a2018bbf8b00/viruses-11-00432-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a72a/6563215/3003ec7916b6/viruses-11-00432-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a72a/6563215/28b5ea9be220/viruses-11-00432-g006.jpg

相似文献

1
The Antigenic Topology of Norovirus as Defined by B and T Cell Epitope Mapping: Implications for Universal Vaccines and Therapeutics.诺如病毒抗原拓扑结构的 B 细胞和 T 细胞表位作图定义:对通用疫苗和治疗的影响。
Viruses. 2019 May 10;11(5):432. doi: 10.3390/v11050432.
2
Type-specific and cross-reactive antibodies and T cell responses in norovirus VLP immunized mice are targeted both to conserved and variable domains of capsid VP1 protein.诺如病毒病毒样颗粒免疫小鼠中种型特异性和交叉反应性抗体及T细胞应答均靶向衣壳VP1蛋白的保守和可变结构域。
Mol Immunol. 2016 Oct;78:27-37. doi: 10.1016/j.molimm.2016.08.009. Epub 2016 Aug 29.
3
Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity.高度变异诺如病毒 GII.4 阻断表位的遗传定位:可能在逃避人群免疫中的作用。
J Virol. 2012 Jan;86(2):1214-26. doi: 10.1128/JVI.06189-11. Epub 2011 Nov 16.
4
Llama nanoantibodies with therapeutic potential against human norovirus diarrhea.具有治疗人类诺如病毒腹泻潜力的骆驼纳米抗体。
PLoS One. 2015 Aug 12;10(8):e0133665. doi: 10.1371/journal.pone.0133665. eCollection 2015.
5
Mapping broadly reactive norovirus genogroup I and II monoclonal antibodies.绘制具有广泛反应性的诺如病毒I型和II型单克隆抗体图谱。
Clin Vaccine Immunol. 2015 Feb;22(2):168-77. doi: 10.1128/CVI.00520-14. Epub 2014 Nov 26.
6
Identification and characterization of antibody-binding epitopes on the norovirus GII.3 capsid.诺如病毒GII.3衣壳上抗体结合表位的鉴定与表征
J Virol. 2014 Feb;88(4):1942-52. doi: 10.1128/JVI.02992-13. Epub 2013 Nov 27.
7
High-Resolution Mapping of Human Norovirus Antigens via Genomic Phage Display Library Selections and Deep Sequencing.高通量人诺如病毒抗原基因文库筛选和深度测序技术研究
J Virol. 2020 Dec 9;95(1). doi: 10.1128/JVI.01495-20.
8
Development of a broad-spectrum therapeutic Fc-nanobody for human noroviruses.广谱人诺如病毒治疗性 Fc-纳米抗体的研制。
J Virol. 2024 Jul 23;98(7):e0070724. doi: 10.1128/jvi.00707-24. Epub 2024 Jul 2.
9
Immunogenetic mechanisms driving norovirus GII.4 antigenic variation.免疫遗传机制驱动诺如病毒 GII.4 抗原变异。
PLoS Pathog. 2012;8(5):e1002705. doi: 10.1371/journal.ppat.1002705. Epub 2012 May 17.
10
Particle conformation regulates antibody access to a conserved GII.4 norovirus blockade epitope.颗粒构象调节抗体对保守的 GII.4 诺如病毒阻断表位的亲和力。
J Virol. 2014 Aug;88(16):8826-42. doi: 10.1128/JVI.01192-14. Epub 2014 May 28.

引用本文的文献

1
Integrated in-silico design and in vivo validation of multi-epitope vaccines for norovirus.诺如病毒多表位疫苗的计算机辅助设计与体内验证一体化研究
Virol J. 2025 May 27;22(1):166. doi: 10.1186/s12985-025-02796-6.
2
Design and evaluation of a multi-epitope subunit vaccine against human norovirus using an immunoinformatics approach.使用免疫信息学方法设计和评估一种针对人类诺如病毒的多表位亚单位疫苗。
Osong Public Health Res Perspect. 2025 Jun;16(3):236-251. doi: 10.24171/j.phrp.2024.0349. Epub 2025 Apr 25.
3
Characterization of cross-reactive, non-neutralizing monoclonal antibodies against a pandemic GII.4 norovirus variant.

本文引用的文献

1
Development of T cell immunity to norovirus and rotavirus in children under five years of age.五岁以下儿童对诺如病毒和轮状病毒的 T 细胞免疫的发展。
Sci Rep. 2019 Mar 1;9(1):3199. doi: 10.1038/s41598-019-39840-9.
2
Human Norovirus: Experimental Models of Infection.人类诺如病毒:感染的实验模型。
Viruses. 2019 Feb 12;11(2):151. doi: 10.3390/v11020151.
3
Structural Basis of Nanobodies Targeting the Prototype Norovirus.针对原型诺如病毒的纳米抗体的结构基础。
针对大流行的GII.4诺如病毒变体的交叉反应性、非中和性单克隆抗体的特性分析
Microbiol Spectr. 2024 Oct 28;12(12):e0114324. doi: 10.1128/spectrum.01143-24.
4
Patterns of the within-host evolution of human norovirus in immunocompromised individuals and implications for treatment.免疫功能低下个体体内人类诺如病毒的宿主内进化模式及其治疗意义。
EBioMedicine. 2024 Nov;109:105391. doi: 10.1016/j.ebiom.2024.105391. Epub 2024 Oct 12.
5
INTRA- AND INTER-HOST EVOLUTION OF HUMAN NOROVIRUS IN HEALTHY ADULTS.人诺如病毒在健康成年人中的宿主内和宿主间进化
bioRxiv. 2024 Sep 5:2023.05.30.542907. doi: 10.1101/2023.05.30.542907.
6
Epidemiological Features of Human Norovirus Genotypes before and after COVID-19 Countermeasures in Osaka, Japan.日本大阪新冠疫情防控措施前后人类诺如病毒基因型的流行病学特征
Viruses. 2024 Apr 22;16(4):654. doi: 10.3390/v16040654.
7
Serological surveillance of GI norovirus reveals persistence of blockade antibody in a Jidong community-based prospective cohort, 2014-2018.2014-2018 年,基于冀东社区的前瞻性队列研究显示,GI 诺如病毒的血清学监测中存在阻断抗体的持续存在。
Front Cell Infect Microbiol. 2023 Dec 18;13:1258550. doi: 10.3389/fcimb.2023.1258550. eCollection 2023.
8
Infant antibody and B-cell responses following confirmed pediatric GII.17 norovirus infections functionally distinguish GII.17 genetic clusters.婴儿抗体和 B 细胞反应在确认的儿科 GII.17 诺如病毒感染后,在功能上区分了 GII.17 遗传簇。
Front Immunol. 2023 Aug 18;14:1229724. doi: 10.3389/fimmu.2023.1229724. eCollection 2023.
9
Predicting Dominant Genotypes in Norovirus Seasons in Japan.预测日本诺如病毒流行季节中的优势基因型
Life (Basel). 2023 Jul 27;13(8):1634. doi: 10.3390/life13081634.
10
Linear epitopes on the capsid protein of norovirus commonly elicit high antibody response among past-infected individuals.诺如病毒衣壳蛋白上的线性表位通常会在既往感染者中引发高抗体反应。
Virol J. 2023 Jun 6;20(1):115. doi: 10.1186/s12985-023-02087-y.
J Virol. 2019 Mar 5;93(6). doi: 10.1128/JVI.02005-18. Print 2019 Mar 15.
4
Norovirus antivirals: Where are we now?诺如病毒抗病毒药物:我们现在在哪里?
Med Res Rev. 2019 May;39(3):860-886. doi: 10.1002/med.21545. Epub 2018 Dec 25.
5
Molecular Dynamics Studies of Histo-Blood Group Antigen Blocking Human Immunoglobulin A Antibody and Escape Mechanism in Noroviruses Upon Mutation.组织血型抗原阻断人免疫球蛋白A抗体的分子动力学研究以及诺如病毒突变后的逃逸机制
J Comput Biol. 2019 Sep;26(9):962-974. doi: 10.1089/cmb.2018.0163. Epub 2018 Dec 20.
6
Identification of a First Human Norovirus CD8 T Cell Epitope Restricted to HLA-A0201 Allele.鉴定首个受 HLA-A0201 等位基因限制的人类诺如病毒 CD8 T 细胞表位。
Front Immunol. 2018 Nov 27;9:2782. doi: 10.3389/fimmu.2018.02782. eCollection 2018.
7
Human Norovirus Neutralized by a Monoclonal Antibody Targeting the Histo-Blood Group Antigen Pocket.一种针对组织血型抗原口袋的单克隆抗体中和人类诺如病毒。
J Virol. 2019 Feb 19;93(5). doi: 10.1128/JVI.02174-18. Print 2019 Mar 1.
8
Human Norovirus Epitope D Plasticity Allows Escape from Antibody Immunity without Loss of Capacity for Binding Cellular Ligands.人类诺如病毒表位 D 的可塑性使其能够逃避抗体免疫而不丧失与细胞配体结合的能力。
J Virol. 2019 Jan 4;93(2). doi: 10.1128/JVI.01813-18. Print 2019 Jan 15.
9
Structural Basis for Human Norovirus Capsid Binding to Bile Acids.人诺如病毒衣壳与胆汁酸结合的结构基础。
J Virol. 2019 Jan 4;93(2). doi: 10.1128/JVI.01581-18. Print 2019 Jan 15.
10
Norovirus-specific mucosal antibodies correlate to systemic antibodies and block norovirus virus-like particles binding to histo-blood group antigens.诺如病毒特异性黏膜抗体与系统抗体相关,可阻断诺如病毒样颗粒与组织血型抗原结合。
Clin Immunol. 2018 Dec;197:110-117. doi: 10.1016/j.clim.2018.09.009. Epub 2018 Sep 19.